DXCM
Ticker
Dexcom Inc
Company
Devices
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
63.8%56.8%31.0%60.2%62.0%55.1%42.6%25.3%43.6%43.1%30.5%27.1%18.8%24.5%11.3% 14.2%
Revenue Growth QoQ
Gross Margin
12.3%37.9%47.0%46.6%62.6%68.0%69.3%66.0%68.5%64.4%63.1%66.4%68.6%64.7%63.2%60.5% 59.0%
EBITDA Margin
-146.4%-88.1%-53.9%-49.1%-13.7%-5.1%-11.5%-8.5%-3.7%-15.2%12.9%19.0%15.0%18.8%21.6%20.3% 22.6%
Operating Margin
-154.4%-93.1%-58.8%-55.8%-18.1%-8.3%-14.2%-11.1%-5.9%-18.1%9.6%15.5%10.9%13.4%16.5%14.9% 17.2%
Profit Margin
-180.3%-113.4%-58.7%-54.6%-18.6%-8.6%-14.3%-11.4%-7.0%-12.3%6.8%25.6%8.9%11.7%14.9%14.3% 16.0%
FCF / EBITDA
97.5%115.6%92.8%86.8%25.1%-56.5%-33.9%-1.0%-98.5%-35.7%70.4%75.5%14.5%55.7%65.3%77.1% 103.9%